Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Septo-Optic Dysplasia
Welcome,
Profile
Billing
Logout
2 Companies
1 Product
1 Product
0 Mechanisms of Action
0 Trials
3 News
||||||||||
Nutropin AQ
(somatropin) /
Ipsen, Roche
Trial completion date:
Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve Hypoplasia
(clinicaltrials.gov) - May 26, 2014
P4
, N=20, Completed,
Sponsor: Children's Hospital Los Angeles
Trial completion date: Dec 2014 --> Feb 2014
|
|||||||||
Nutropin AQ
(somatropin) /
Ipsen, Roche
Enrollment change:
Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve Hypoplasia
(clinicaltrials.gov) - May 26, 2014
P4
, N=20, Completed,
Sponsor: Children's Hospital Los Angeles
Trial completion date: Dec 2014 --> Feb 2014 N=38 --> 20
|
|||||||||
Nutropin AQ
(somatropin) /
Ipsen, Roche
Trial completion:
Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve Hypoplasia
(clinicaltrials.gov) - May 26, 2014
P4
, N=20, Completed,
Sponsor: Children's Hospital Los Angeles
N=38 --> 20 Recruiting --> Completed